Navigation Links
U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
Date:8/12/2008

CALGARY, Aug. 12 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the U.S. National Cancer Institute (NCI), part of the National Institutes of Health, has started enrolment in a Phase 2 clinical trial for patients with metastatic melanoma using systemic administration of REOLYSIN(R), Oncolytics' proprietary formulation of the human reovirus. The trial is being carried out by the Mayo Phase 2 Consortium under the NCI's Clinical Trials Agreement with Oncolytics, while Oncolytics will provide clinical supplies of REOLYSIN(R). The Principal Investigator is Dr. Evanthia Galanis of the Mayo Clinic Cancer Center.

The primary objectives of the study are to assess the antitumour effects of REOLYSIN(R) in patients with metastatic malignant melanoma, as well as the safety profile of REOLYSIN(R). Secondary objectives include assessment of progression free survival and overall survival.

Patients will receive systemic administration of REOLYSIN(R) at a dose of 3x10(10) TCID(50) per day on days 1-5 of each 28 day cycle, and patients may receive up to 12 cycles of treatment. The trial is expected to enroll up to 47 patients with metastatic melanoma.

Approximately 60,000 people are diagnosed with melanoma in the U.S. every year.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
2. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
3. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
4. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
5. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
6. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
7. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
8. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
9. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
11. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BETHESDA, Md. , Sept. 16, 2014 ... CHDX ) announced that, at a special meeting ... previously announced merger agreement (the "Merger  Agreement") by and ... Healthy Harmony Acquisition, Inc. ("Merger Sub"). Parent is an ... ("Fosun") and Ms. Roberta Lipson , the CEO ...
(Date:9/16/2014)... 16, 2014 Research and Markets has ... 2014-2018" report to their offering. Animal ... animals. Animal vaccines are generally prepared from weakened or dead ... healthy state. Some of the animal vaccines are also formulated ... subunits or toxic components. These components act ...
(Date:9/16/2014)... QPID Health , a leader in clinical ... Boston and their first West Coast ... 175 Franklin Street in Boston , and will ... new Southern California office will be ... help meet the demands of customers nationwide.  Both new locations ...
Breaking Medicine Technology:Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2
... Researchers from the University of Cincinnati presented results from ... Society 2011 Annual Meeting today, demonstrating how PEM-guided ... for breast cancer patients.   PEM ... the location as well as the metabolic phase of ...
... F. Kennedy designated the month of May as Older Americans ... tradition to pay tribute to older adults. At that time, ... to the Administration on Aging. In 2009, this number totaled ... older adults rely on the support of their loved ones, ...
Cached Medicine Technology:Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure 2May is Older Americans Month 2
(Date:9/16/2014)... 14, 2014 A new study found that ... stenting of true coronary bifurcation lesions yields similar ... DKCRUSH-VI clinical trial is the first study to ... were reported today at the 26th annual Transcatheter ... Cardiovascular Research Foundation (CRF), TCT is the world,s ...
(Date:9/16/2014)... 16, 2014 Programs and policies that ... of billions of dollars in savings for the US ... Commonwealth Fund. To help spur these types of improvements, ... 10 collaborative groups from across the country to field ... ) - a handbook designed to assist groups working ...
(Date:9/16/2014)... 2014 As part of its Latinos ... Citizens (LULAC) will host the second annual health festival ... feature free health screenings for osteoporosis, HIV, and high ... and cholesterol levels as well as bone marrow typing. ... under 6 years old , The event will also ...
(Date:9/16/2014)... Dennis Thompson HealthDay Reporter ... combination drug therapy aimed at opening the airways and ... older adults with chronic obstructive pulmonary disease (COPD), especially ... COPD patients who received a combination of long-acting beta ... or require hospitalization because of their breathing disorder, compared ...
(Date:9/16/2014)... NC (PRWEB) September 16, 2014 Danny ... on a Fall workshop tour with events throughout the ... the natural running movement and has taught a full ... is now offering ChiWalk-Run and ChiWalking tracks at his ... enjoy the benefits of the Chi techniques. , Workshop ...
Breaking Medicine News(10 mins):Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2Health News:Combo Therapy Best for COPD: Study 2Health News:Combo Therapy Best for COPD: Study 3Health News:Join ChiRunning® Founder, Danny Dreyer, on Fall 2014 US Workshop 2Health News:Join ChiRunning® Founder, Danny Dreyer, on Fall 2014 US Workshop 3
... tau helped in the reduction of Alzheimer’s symptoms in mice. ... treatment// to a deadly brain disorder, scientists hope. ... said, “If this strategy also works in humans, it could ... ,The researchers, whose work is published in the journal Science, ...
... Gastroenterology suggests that smoking may determine which part of ... from Crohn’s disease. Where the disease is located often ... ,“In patients who smoke, Crohn’s disease tends ... than the colon,” says study author Dr. Marian Aldhous. ...
... is seeking to raise glaucoma awareness among Mexican-Americans, who have ... Grande Valley Dispatch reports. ,Mexican-Americans over age ... history of glaucoma all face a higher risk for the ... most common form glaucoma. ,The rate increases ...
... American Cancer Society is launching a major new cancer research ... large-scale population research// in the United States to discover the ... ,The Cancer Prevention Study 3 (CPS-3) aims to enroll ... adults across the United States to help pave the way ...
... indicated that the culprit to most health threat is the ... and heating. According to the UN 5% of the preventable ... ,This study is based on a new estimate ... the physical, chemical, and biological characteristics of air in the ...
... women who like their meat smoked or barbequed. // ... consumed the most grilled, barbecued or smoked red meat over their ... meat-eaters who also skimped on fruit and vegetables had a 74 ... Susan E. Steck of the University of South Carolina in Columbia, ...
Cached Medicine News:Health News:American Cancer Society Launches Major New Study 2Health News:American Cancer Society Launches Major New Study 3Health News:Barbeque Lovers Warned To Load On Fruits And Vegetables 2
... 265 is a highly accurate portable, waterproof system ... measurements. Temperature compensated pH results can be obtained ... a 3-in-1 electrode. • This GLP/GMP compliant system ... printer or a computer. Up to 100 data ...
... a highly accurate portable system for pH, mV ... pH results can be obtained when used with ... • This GLP/GMP compliant system includes an RS-232 ... computer. Up to 100 data sets can be ...
... Over-sized compressor. Triple pane thermal glass. ... System No plumbing required. Equipped with a ... on Parts & Labor and an Additional 4 ... as a chromatography unit which includes two access ...
... equipped, waterproof system for pH, mV (ORP), relative ... pH results can be obtained when used with ... Up to five custom buffers are supported. • ... to connect to a printer or a computer. ...
Medicine Products: